BIND THERAPEUTICS INC's ticker is BINDQXXXX and the CUSIP is 05548N107. A total of 37 filers reported holding BIND THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $45,000 | -82.2% | 114,786 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $253,000 | -3.8% | 114,786 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $263,000 | -48.6% | 114,786 | 0.0% | 0.00% | -50.0% |
| Q3 2015 | $512,000 | -60.1% | 114,786 | -50.0% | 0.01% | -14.3% |
| Q2 2015 | $1,284,000 | +103.8% | 229,572 | +100.0% | 0.01% | -22.2% |
| Q1 2015 | $630,000 | -32.8% | 114,786 | +84.9% | 0.01% | -75.7% |
| Q4 2013 | $937,000 | -35.2% | 62,087 | -39.4% | 0.04% | -37.3% |
| Q3 2013 | $1,447,000 | – | 102,500 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 155,000 | $2,123,500,000 | 1.67% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 604,207 | $8,426,000 | 0.50% |
| BVF INC/IL | 150,000 | $2,264,000 | 0.40% |
| EMERALD ADVISERS, LLC | 419,752 | $6,334,000 | 0.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 256,384 | $3,869,000 | 0.20% |
| Alyeska Investment Group, L.P. | 62,087 | $937,000 | 0.04% |
| THOMPSON DAVIS & CO., INC. | 1,500 | $23,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 13,000 | $196,000 | 0.03% |
| SSI INVESTMENT MANAGEMENT LLC | 23,580 | $356,000 | 0.03% |
| TFS CAPITAL LLC | 20,933 | $316,000 | 0.02% |